Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Enzo Biochem Inc

ENZ
Current price
1.14 USD -0.01 USD (-0.87%)
Last closed 1.16 USD
ISIN US2941001024
Sector Healthcare
Industry Diagnostics & Research
Exchange NYSE
Capitalization 59 558 272 USD
Yield for 12 month -8.06 %
1Y
3Y
5Y
10Y
15Y
ENZ
21.11.2021 - 28.11.2021

Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company also licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. The company was incorporated in 1976 and is headquartered in Farmingdale, New York. Address: 21 Executive Blvd, Farmingdale, NY, United States, 11735

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.5 USD

P/E ratio

Dividend Yield

Current Year

+31 907 000 USD

Last Year

+31 061 000 USD

Current Quarter

+7 526 000 USD

Last Quarter

+8 022 000 USD

Current Year

+14 632 000 USD

Last Year

+11 566 000 USD

Current Quarter

+3 220 000 USD

Last Quarter

+3 733 000 USD

Key Figures ENZ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -11 093 000 USD
Operating Margin TTM -38.75 %
PE Ratio
Return On Assets TTM -7.44 %
PEG Ratio
Return On Equity TTM -14.59 %
Wall Street Target Price 5.5 USD
Revenue TTM 31 907 000 USD
Book Value 1.07 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 7.2 %
Dividend Yield
Gross Profit TTM 11 566 000 USD
Earnings per share -0.19 USD
Diluted Eps TTM -0.19 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -81.73 %

Dividend Analytics ENZ

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ENZ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 15.11.2024
Forward Annual Dividend Yield
Last Split Factor 105:100
Payout Ratio
Last Split Date 21.10.2004
Dividend Date 02.12.2024

Stock Valuation ENZ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.3516
Price Sales TTM 1.883
Enterprise Value EBITDA -3.2705
Price Book MRQ 1.0707

Financials ENZ

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ENZ

For 52 weeks

0.99 USD 1.5 USD
50 Day MA 1.13 USD
Shares Short Prior Month 478 733
200 Day MA 1.16 USD
Short Ratio 7.24
Shares Short 500 264
Short Percent 1.26 %